PHARMASEAL International
PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health. The company's platform Engility® simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility® utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
Last updated on
About PHARMASEAL International
Founded
2017Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$3MCategory
Industry
PharmaceuticalsLocation
City
NottinghamState
NottinghamshireCountry
United KingdomPHARMASEAL International
Find your buyer within PHARMASEAL International